Liminatus Pharma Stock (NASDAQ:LIMN)


Chart

Previous Close

$20.31

52W Range

$4.40 - $26.68

50D Avg

$9.67

200D Avg

$9.67

Market Cap

$375.13M

Avg Vol (3M)

$357.75K

Beta

0.17

Div Yield

-

LIMN Company Profile


Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

3

IPO Date

May 01, 2025

Website

LIMN Performance